Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02816216 · ClinicalTrials.gov registry record · NA
Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability
A NA study, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02816216: Completed NA study, sponsored by 3-C Institute for Social Development.
NCT02816216 is a NA study that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02816216, a NA study, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This project will fully develop and preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control. In addition to developing a highly novel product for adolescents with asthma, the research proposed for this project will address unique scientific questions. Despite the high asthma prevalence among adolescents, few interventions have specifically targeted adolescents. This study is innovative in that it is among the few to focus on adolescents, who are often overlooked by the healthcare system. This research will assess factors associated with successful implementation of CampAir, thereby providing new information regarding how e-health interventions can be effectively developed and implemented for use with adolescents with asthma.
Primary Outcome
Participants will complete a brief online survey to rate the content modules and other components of the CampAir program in the areas of (a) engagement, (b) quality of content, (c) quality of flow, (d) value, (e) usefulness, (f) relevance to real-life, (g) usability. Open-ended questions will also be included to gather qualitative comments and recommendations for each area assessed. This measure will be repeated for each review with questions tailored to the particular components and modules rev
Interventions
- BEHAVIORAL CampAir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-05-01 |
| Est. Completion | 2016-10-05 |
| Phase | NA |
What the finished NCT02816216 record still lists
NCT02816216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which CampAir is the first listed.
NCT02816216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02816216 about?
NCT02816216 is a clinical study titled "Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability". This project will fully develop and preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control. In addition to developing a ...
What is the current status of trial NCT02816216?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-05-01. Estimated completion is 2016-10-05.
What interventions are being tested in trial NCT02816216?
The interventions under investigation include: CampAir (BEHAVIORAL).
Who is sponsoring clinical trial NCT02816216?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02816216's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy